Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

BMP Sunstone Says Propess® Recommended for Induction of Labor in China

publication date: Feb 28, 2008

The recently renamed BMP Sunstone Corporation (formerly Beijing Med-Pharm) reported that Propess® received a recommendation as the first-line treatment for labor induction in late-stage pregnancy. The recommendation came from the Obstetrics Group at the Obstetrics and Gynecology Branch of the Chinese Medical Association. BMP Sunstone began its efforts to sell and market Propess® in China in 2005, after licensing the drug from its manufacturer, Cytokine PharmaSciences, Inc. of Pennsylvania. More details...

Stock Symbol: (NSDQ: BJGP)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital